Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

未开盘 07-25 16:00:00 EDT

12.67

-0.12

-0.94%

盘后12.45

-0.22-1.74%

19:20 EDT

最高12.70	最低12.67	成交量2,467
今开12.70	昨收12.79	日振幅0.23%
总市值8,240万	流通市值3,872万	总股本650.39万
成交额3.11万	换手率0.08%	流通股本305.59万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":12.67,"timestamp":1721937600000,"preClose":12.79,"halted":0,"volume":2467,"hourTrading":{"tag":"盘后","latestPrice":12.45,"preClose":12.67,"latestTime":"19:20 EDT","volume":205,"amount":2553.18,"timestamp":1721949649178},"delay":0,"floatShares":3055920,"shares":6503913,"eps":-18.961046,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.12,"latestTime":"07-25 16:00:00 EDT","open":12.7,"high":12.7,"low":12.67,"amount":31124.495978,"amplitude":0.002346,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.961046,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721980800000},"adr":0,"listingDate":1616126400000,"adjPreClose":12.79,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.45,"preClose":12.67,"latestTime":"19:20 EDT","volume":205,"amount":2553.18,"timestamp":1721949649178},"volumeRatio":0.508178,"impliedVol":5.6162,"impliedVolPercentile":0.9897},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2451691845","title":"Instil Bio, Inc.盘中异动 股价大跌6.66%报12.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451691845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451691845?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:52","pubTimestamp":1721137979,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时52分，Instil Bio, Inc.股票出现波动，股价快速下挫6.66%。截至发稿，该股报12.61美元/股，成交量6686股，换手率0.10%，振幅1.52%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215300941f7717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215300941f7717&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2451283066","title":"Instil Bio, Inc.盘中异动 早盘快速上涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451283066","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451283066?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:39","pubTimestamp":1721050778,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时39分，Instil Bio, Inc.股票出现波动，股价大幅上涨6.13%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Aeon Biopharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大，Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为96.73%、53.50%、24.06%，振幅较大的相关个股有Aeon Biopharma, Inc.、Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为29.64%、18.40%、12.78%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213938aef9c05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213938aef9c05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2450355895","title":"Instil Bio, Inc.股价拉升25.77% 市值涨2044.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355895","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450355895?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791099,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，Instil Bio, Inc.股票出现异动，股价大幅上涨25.77%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131399f3c0102&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131399f3c0102&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2449221482","title":"Instil Bio, Inc.盘中异动 股价大跌5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449221482","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449221482?lang=zh_cn&edition=full","pubTime":"2024-07-06 03:58","pubTimestamp":1720209503,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日03时58分，Instil Bio, Inc.股票出现波动，股价大幅下跌5.87%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706035823941f47ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706035823941f47ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2446027556","title":"Instil Bio, Inc.盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446027556","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446027556?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:07","pubTimestamp":1719497250,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时07分，Instil Bio, Inc.股票出现异动，股价快速拉升6.08%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627220730aef6f188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627220730aef6f188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2446883822","title":"Instil Bio, Inc.盘中异动 大幅跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446883822","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446883822?lang=zh_cn&edition=full","pubTime":"2024-06-25 02:47","pubTimestamp":1719254867,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日02时47分，Instil Bio, Inc.股票出现波动，股价急速下跌5.13%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.88%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625024748aef65745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625024748aef65745&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2444182441","title":"Instil Bio, Inc.盘中异动 下午盘股价大跌5.17%报9.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444182441","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444182441?lang=zh_cn&edition=full","pubTime":"2024-06-18 02:08","pubTimestamp":1718647716,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日02时08分，Instil Bio, Inc.股票出现波动，股价急速跳水5.17%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biocardia Inc C/Wts 06/08/2024涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4980.39%、2875.56%、178.28%，振幅较大的相关个股有Mustang Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为276.85%、79.35%、53.30%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618020836af8de6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618020836af8de6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2443604405","title":"Instil Bio, Inc.盘中异动 下午盘股价大跌6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443604405","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443604405?lang=zh_cn&edition=full","pubTime":"2024-06-13 01:39","pubTimestamp":1718213955,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日01时39分，Instil Bio, Inc.股票出现波动，股价快速跳水6.27%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301391596813c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301391596813c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2442122643","title":"Instil Bio, Inc.盘中异动 股价大涨6.02%报11.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442122643","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442122643?lang=zh_cn&edition=full","pubTime":"2024-06-12 01:30","pubTimestamp":1718127022,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日01时30分，Instil Bio, Inc.股票出现波动，股价急速上涨6.02%。截至发稿，该股报11.10美元/股，成交量3007股，换手率0.05%，振幅4.01%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612013022941edca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612013022941edca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2440499051","title":"Instil Bio, Inc.盘中异动 早盘股价大涨6.83%报11.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440499051","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440499051?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:11","pubTimestamp":1717423916,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时11分，Instil Bio, Inc.股票出现异动，股价大幅上涨6.83%。截至发稿，该股报11.42美元/股，成交量124股，换手率0.00%，振幅0.00%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603221157af8bade6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603221157af8bade6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2439678964","title":"Instil Bio, Inc.盘中异动 下午盘大幅拉升6.65%报11.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439678964","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439678964?lang=zh_cn&edition=full","pubTime":"2024-05-31 01:14","pubTimestamp":1717089294,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日01时14分，Instil Bio, Inc.股票出现异动，股价大幅上涨6.65%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531011454aef2949e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531011454aef2949e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2434857616","title":"Instil Bio Inc 公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434857616","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434857616?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:26","pubTimestamp":1715351190,"startTime":"0","endTime":"0","summary":"   * Instil Bio Inc   报告了截至3月底的季度调整后每股亏损3.74美元，高于去年同期的每股收益8.80美元。两位分析师对该季度的平均预期是每股亏损 2.23 美元。华尔街预期为每股亏损 2.30 美元至 2.16 美元。* Instil Bio Inc 公布的季度每股收益为亏损 3.74 美元。* 该公司当季亏损2430万美元。* Instil Bio Inc 本季度股价上涨了 4.0%，今年迄今为止上涨了 47.4%。5月10日 - 预测变化   * 在过去三个月里，分析师的平均盈利预测上升了约 25.5%。华尔街对 Instil Bio Inc 的 12 个月目标价中位数为 18.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2434805854","title":"Instil Bio, Inc.盘中异动 早盘快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434805854","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434805854?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:33","pubTimestamp":1715348016,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时33分，Instil Bio, Inc.股票出现波动，股价急速拉升5.16%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102133377a5940b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102133377a5940b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2433302788","title":"Instil Bio, Inc.盘中异动 早盘快速下挫5.29%报10.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433302788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433302788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:48","pubTimestamp":1715089694,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时48分，Instil Bio, Inc.股票出现异动，股价急速跳水5.29%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1153.46%、134.16%、47.06%，振幅较大的相关个股有Tc Biopharm  Plc、Corvus Pharmaceuticals, Inc.、Clearmind Medicine Inc.，振幅分别为31.03%、26.70%、23.93%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072148157a5885da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072148157a5885da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2433720641","title":"Instil Bio Inc   预计每股亏损2.23美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433720641","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433720641?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:34","pubTimestamp":1715085279,"startTime":"0","endTime":"0","summary":"   * Instil Bio Inc    预计在5月9日公布截至0001年1月1日的业绩(估计)，季度收入将没有变化。*    * LSEG 的分析师平均预计 Instil Bio Inc 每股亏损 2.23 美元。* 华尔街对 Instil Bio Inc 的 12 个月目标价中位数为 18.00 美元，高于其最新收盘价 11.54 美元。5月7日 - 本摘要于北京时间 5 月 7 日 12:34 机器生成。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL"],"gpt_icon":0},{"id":"2431837539","title":"在外部环境挑战下，药明康德2024年第一季度达成目标，保持稳健经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2431837539","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431837539?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:02","pubTimestamp":1714388520,"startTime":"0","endTime":"0","summary":"2024年第一季度，公司新增客户超过300家，过去12个月服务的活跃客户超过6,000家，全球各地客户对公司服务的需求持续增长。化学业务D&M分子管线保持快速增长，报告期内累计新增分子337个；截至2024年第一季度末，D&M分子管线总数总计3,286个，其中商业化和临床III期项目在报告期内合计新增11个。管理层评论 药明康德董事长兼首席执行官李革博士表示：\"2024年第一季度，公司如期达成设定目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4399640_ZH99640_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2045819591.USD","BK0216","02359","LU1997245177.USD","LU2242644610.SGD","LU0708995583.HKD","BK4121","LU1046422090.SGD","BK1576","BK4505","LU1997245094.SGD","LU0320764599.SGD","BK1141","BK4139","LU0456842615.SGD","TIL","BK1583","LU0052750758.USD","CTA","LU2125910500.SGD","603259","WUXAY"],"gpt_icon":0},{"id":"2430284429","title":"Instil Bio, Inc.盘中异动 急速跳水5.23%报10.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430284429","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430284429?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:51","pubTimestamp":1714053080,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时51分，Instil Bio, Inc.股票出现异动，股价大幅下挫5.23%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.40%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252151207a55b51c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252151207a55b51c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2427788008","title":"Instil Bio, Inc.盘中异动 下午盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427788008","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427788008?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:07","pubTimestamp":1713208036,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日03时07分，Instil Bio, Inc.股票出现波动，股价大幅跳水5.00%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发一种创新的细胞治疗管道，自体肿瘤浸润淋巴细胞，或TIL，治疗癌症患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416030716861e5e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416030716861e5e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2426762202","title":"美国研究综述-Cheesecake Factory、Netflix、Texas Roadhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2426762202","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426762202?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:04","pubTimestamp":1712905476,"startTime":"0","endTime":"0","summary":"    路透社4月12日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cheesecake Factory、Netflix 和 Texas Roadhouse。要闻             * Cheesecake Factory Inc   ：斯蒂芬斯恢复覆盖，给予增持评级             * Netflix Inc   ：Piper Sandler将目标价从550美元上调至600美元             * Texas Roadhouse Inc   ：斯蒂芬斯恢复对该公司的研究，给予等权重评级 以下是路透社周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","ALPN","REGN","DAL","META","BK4550","SGXZ99366536.SGD","SGXZ23171101.USD","TXRH","DRI","BK4551","BK4548","LU0642271901.SGD","CHUY","FAST","LU0234570918.USD","BK4560","BK4567","RVMD","MDLZ","CAKE","LU0320765992.SGD","ELVN","LU0353189680.USD","LU1435385759.SGD","TIL","PMVP","TLRY","PZZA","WEN","CHRD","OVV","BK4507","CMAX","NFLX","BK4500","IPSC","LU0433182093.SGD","IE00BMPRXN33.USD","LU0234572021.USD","RTX","BA","CMG","BK4581","LU0208291251.USD","STKS","RENT","IE00B7SZLL34.SGD","DPZ","DT"],"gpt_icon":0},{"id":"2422523461","title":"Instil Bio, Inc.盘中异动 股价大跌5.00%报11.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422523461","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422523461?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:26","pubTimestamp":1711383994,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日00时26分，Instil Bio, Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报11.01美元/股，成交量7786股，换手率0.12%，振幅4.14%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发一种创新的细胞治疗管道，自体肿瘤浸润淋巴细胞，或TIL，治疗癌症患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032600263587e7b886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032600263587e7b886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.2863},{"period":"3month","weight":0.1953},{"period":"6month","weight":0.0611},{"period":"1year","weight":0.0811},{"period":"ytd","weight":0.6627}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.173004},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.036947},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.080585},{"month":4,"riseRate":0.25,"avgChangeRate":-0.133235},{"month":5,"riseRate":0,"avgChangeRate":-0.094412},{"month":6,"riseRate":0.25,"avgChangeRate":-0.066045},{"month":7,"riseRate":0.5,"avgChangeRate":0.055496},{"month":8,"riseRate":0.333333,"avgChangeRate":0.000223},{"month":9,"riseRate":0,"avgChangeRate":-0.057388},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.103927},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.201575},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.207775}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}